To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Imara goes public
Imara, a developer of new treatments for patients suffering from rare inherited genetic disorders of hemoglobin, has raised $75.2 million for its IPO after pricing its 4.7 million shares at $16 per share.
